GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 44.85
+0.05 (0.11%)
Jan 22, 2026, 1:30 PM CST
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.86 billion as of January 21, 2026. Its market cap has decreased by -6.08% in one year.
Market Cap
1.86B
Enterprise Value
1.91B
Revenue
654.88M
Ranking
n/a
PE Ratio
115.56
Stock Price
44.85
Market Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.86B, a decrease of -14.56%. That is a compound annual growth rate of -1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.86B | -7.15% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |